ACCSYS TECHNOLOGIES PLC (AXS.AS)       0.737  0 (-0.41%)

0.737  0 (-0.41%)

GB00BQQFX454 - Common Stock


Fundamental Rating

2

Overall AXS gets a fundamental rating of 2 out of 10. We evaluated AXS against 5 industry peers in the Paper & Forest Products industry. Both the profitability and financial health of AXS have multiple concerns. AXS is not valued too expensively and it also shows a decent growth rate.

Note: AXS has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

0

AXS has a very weak Piotroski-F score of 2.00. This is an indication of health and profitability issues for AXS.

VS Industry

Valuation

Valuation Rating

4

AXS's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
With a Forward Price/Earnings Ratio of 16.72, AXS is valued correctly.
With a price book ratio of 1.24, AXS is valued correctly.

Compared to an average industry price book ratio of 1.24, AXS is valued in line with its industry peers.
Compared to an average industry Enterprise Value to EBITDA ratio of 20.38, AXS is valued in line with its industry peers.
The Price/Earnings Ratio is negative for AXS. In the last year negative earnings were reported.
VS Industry

Price/Book (1.24) VS Industry: 50% outperformed.

1.85
0.90

Enterprise Value/ EBITDA (20.38) VS Industry: 50% outperformed.

20.38
20.38

Growth

Growth Rating

6

Based on estimates for the next 5 years, AXS will show a very strong growth in Earnings Per Share. The EPS will grow by 95.35% on average per year.
The Revenue has been growing by 16.41% on average over the past 5 years. This is quite good.
AXS is expected to show quite a strong growth in Revenue. In the coming 5 years, the Revenue will grow by 14.86% yearly.

AXS shows a small growth in Revenue. In the last year, the Revenue has grown by 9.19%.
The Revenue growth is stable: in the next 5 years the growth will be about the same than in the last 5 years.
AXS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -7964.90%.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -7964.9% 287.39% 153.5% 129.02% 95.35%
Revenue16.41% 17.16% 9.19% 29.23% 24.06% 20.64% 14.86%

Health

Health Rating

2

The Debt to Equity ratio of AXS is way better than the industry averages. AXS has a better rating than 100% of its industry peers.
AXS has a Current Ratio of 1.23. This is a normal value and indicates that AXS is financially healthy and should not expect problems in meeting its short term obligations.
When comparing the Current Ratio of AXS to the average industry Current Ratio of 1.40, AXS is less able to pay its short term obligations than its industry peers.
A Quick Ratio of 0.59 indicates that AXS may have some problems paying its short term obligations.

When comparing the Quick Ratio of AXS to the average industry Current Ratio of 1.11, AXS is less able to pay its short term obligations than its industry peers. 100% of its industry peers have a better Quick Ratio.
AXS has an Altman-Z score of 0.76. This is a bad value and indicates that AXS is not financially healthy and even has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 1.88, AXS is in worse financial state than most of its industry peers. 100% of its industry peers have a better Altman-Z score.
AXS has a very weak Piotroski-F score of 2.00. This is an indication of health and profitability issues for AXS.
VS Industry

Debt/Equity (0.45) VS Industry: 100% outperformed.

0.94
0.45

Quick Ratio (0.59) VS Industry: 0% outperformed.

0.59
1.58

Current Ratio (1.23) VS Industry: 25% outperformed.

1.03
2.01

Altman-Z (0.76) VS Industry: 0% outperformed.

0.76
2.77

Dividend

Dividend Rating

0

No dividends for AXS!.

ACCSYS TECHNOLOGIES PLC0.737

AMS:AXS (3/28/2023, 7:00:00 PM)0 (-0.41%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap161.15M
Analysts86.67
Price Target1.6 (117.1%)
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
PT rev (1m)10.28%
PT rev (3m)5.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)29%
EPS NY rev (3m)29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.91%
Revenue NY rev (3m)2.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.72
P/S 1.3
P/FCF N/A
P/OCF N/A
P/B 1.24
P/tB 1.3
EV/EBITDA 20.38
EPS(TTM)-0.12
EYN/A
EPS(NY)0.04
Fwd EY5.98%
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.56
BVpS0.6
TBVpS0.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 1.65%
ROICexc 1.82%
ROICexgc 1.89%
OM 3.47%
PM N/A
GM 29.91%
ROICexgc(3y)1.77%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc(3y)1.65%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.3%
GM growth 5Y3.25%
F-Score2
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 7.28
Cap/Depr 760.19%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.59
Altman-Z 0.76
F-Score2
WACC7.61%
ROIC/WACC0.25
Cap/Depr(3y)453.15%
Cap/Depr(5y)713.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-7964.9%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-2630.21%
EPS Next Y287.39%
EPS Next 2Y153.5%
EPS Next 3Y129.02%
EPS Next 5Y95.35%
Revenue growth 1Y9.19%
Revenue growth 3Y17.16%
Revenue growth 5Y16.41%
Revenue growth Q2Q4.71%
Revenue Next Year29.23%
Revenue Next 2Y24.06%
Revenue Next 3Y20.64%
Revenue Next 5Y14.86%
EBIT growth 1Y-9.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year265.64%
EBIT Next 3Y95.97%
EBIT Next 5Y69.38%
FCF growth 1Y-385.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-105.46%
OCF growth 3Y96.29%
OCF growth 5YN/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext